The Joint Corp. Reports $14.8 Million Revenue in Q1 2026, 13.3% Increase Year-Over-Year

The Joint Corp. reported a total revenue of $14.8 million for the first quarter of 2026, marking a 13.3% increase from $13.1 million in the same period of the previous year. This growth was primarily driven by a significant rise in franchise fees, which surged by 38.2% to $1.1 million, and advertising fund revenue, which increased by 58.1% to $3.6 million. The company also noted a slight decline in royalty fees, which fell by 0.5% to $8.0 million. The net income from continuing operations was $1.1 million, a notable recovery from a loss of $0.5 million in the prior year, reflecting a positive shift in operational performance.

In terms of operational metrics, The Joint Corp. ended the quarter with 943 clinics in operation, comprising 868 franchised clinics and 75 company-owned or managed clinics. The company refranchised 37 clinics in 2025 and has continued to pursue a strategy of refranchising its corporate clinics, which it initiated in 2023. This strategic shift aims to enhance growth by leveraging its franchise model, with a focus on expanding its presence in key markets across North America. The company has also reported a decrease in comparable same-store sales of 4.2% for clinics open for at least 13 months.

The financial results reflect a decrease in total cost of revenues, which fell by 8.4% to $2.7 million, attributed to reduced regional developer royalties. Selling and marketing expenses increased by 6.0% to $3.7 million, driven by heightened marketing campaign efforts. General and administrative expenses rose slightly by 2.5% to $7.1 million, primarily due to increased workers' compensation insurance and professional services costs. The company reported an operating income of $873,668, a significant turnaround from the previous year's loss, indicating improved operational efficiency.

Looking ahead, The Joint Corp. anticipates continued challenges from macroeconomic factors such as inflation, labor shortages, and elevated interest rates, which may impact consumer spending on chiropractic services. The company remains committed to its refranchising strategy and aims to capitalize on the growing demand for affordable, non-insurance-based chiropractic care. The management believes that its existing cash reserves, anticipated cash flows, and access to credit will be sufficient to meet operational and investment needs for at least the next 12 months, despite the uncertain economic landscape.